| 2018 |
Hammond MA, Wallace JM, Allen MR, Siegmund T. Incorporating tissue anisotropy and heterogeneity in finite element models of trabecular bone altered predicted local stress distributions. Biomech Model Mechanobiol. April 2018;17(2):605-614. |
4 |
3 |
| 2006 |
Allen MR, Iwata K, Phipps R, Burr DB. Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate. Bone. October 2006;39(4):872-879. |
50 |
35 |
| 2006 |
Allen MR, Iwata K, Sato M, Burr DB. Raloxifene enhances vertebral mechanical properties independent of bone density. Bone. November 2006;39(5):1130-1135. |
31 |
21 |
| 2007 |
Wallace JM, Rajachar RM, Allen MR, Bloomfield SA, Robey PG, Young MF, Kohn DH. Exercise-induced changes in the cortical bone of growing mice are bone- and gender-specific. Bone. April 2007;40(4):1120-1127. |
29 |
23 |
| 2008 |
Wang X, Allen MR, Burr DB, Lavernia EJ, Jeremić B, Fyhrie DP. Identification of material parameters based on ohr–Coulomb failure criterion for bisphosphonate treated canine vertebral cancellous bone. Bone. October 2008;43(4):775-780. |
18 |
13 |
| 2010 |
Gourion-Arsiquaud S, Allen MR, Burr DB, Vashishth D, Tang SY, Boskey AL. Bisphosphonate treatment modifies canine bone mineral and matrix properties and their heterogeneity. Bone. March 2010;46(3):666-672. |
30 |
22 |
| 2011 |
Allen MR, Burr DB. Bisphosphonate effects on bone turnover, microdamage, and mechanical properties: what we think we know and what we know that we don't know. Bone. July 2011;49(1):56-65. |
31 |
27 |
| 2012 |
Tu X, Rhee Y, Condon KW, Bivi N, Allen MR, Dwyer D, Stolina M, Turner CH, Robling AG, Plotkin LI, Bellido T. Sost downregulation and local Wnt signaling are required for the osteogenic response to mechanical loading. Bone. January 2012;50(1):209-217. |
51 |
43 |
| 2013 |
Gallant MA, Brown DM, Organ JM, Allen MR, Burr DB. Reference-point indentation correlates with bone toughness assessed using whole-bone traditional mechanical testing. Bone. March 2013;53(1):301-305. |
22 |
19 |
| 2014 |
Gallant MA, Brown DM, Hammond M, Wallace JM, Du J, Deymier-Black AC, Almer JD, Stock SR, Allen MR, Burr DB. Bone cell-independent benefits of raloxifene on the skeleton: a novel mechanism for improving bone material properties. Bone. April 2014;61:191-200. |
20 |
12 |
| 2014 |
Bajaj D, Geissler JR, Allen MR, Burr DB, Fritton JC. The resistance of cortical bone tissue to failure under cyclic loading is reduced with alendronate. Bone. July 2014;64:57-64. |
16 |
14 |
| 2020 |
Berman AG, Organ JM, Allen MR, Wallace JM. Muscle contraction induces osteogenic levels of cortical bone strain despite muscle weakness in a mouse model of osteogenesis imperfecta. Bone. March 2020;132:115061. |
1 |
0 |
| 2021 |
Metzger CE, Swallow EA, Stacy AJ, Tippen SP, Hammond MA, Chen NX, Moe SM, Allen MR. Reversing cortical porosity: cortical pore infilling in preclinical models of chronic kidney disease. Bone. February 2021;143:115632. |
5 |
0 |
| 2021 |
Tippen SP, Noonan ML, Ni P, Metzger CE, Swallow EA, Sacks SA, Chen NX, Thompson WR, Prideaux M, Atkins GJ, Moe SM, Allen MR, White KE. Age and sex effects on FGF23-mediated response to mild phosphate challenge. Bone. May 2021;146:115885. |
4 |
2 |
| 2021 |
Metzger CE, Swallow EA, Stacy AJ, Allen MR. Strain-specific alterations in the skeletal response to adenine-induced chronic kidney disease are associated with differences in parathyroid hormone levels. Bone. July 2021;148:115963. |
5 |
1 |
| 2021 |
Frank M, Grabos A, Reisinger AG, Burr DB, Pahr DH, Allen MR, Thurner PJ. Effects of anti-resorptive treatment on the material properties of individual canine trabeculae in cyclic tensile tests. Bone. September 2021;150:115995. |
0 |
0 |
| 2022 |
Tippen SP, Metzger CE, Swallow EA, Sacks SA, Wallace JM, Allen MR. The combination of aging and chronic kidney disease leads to an exacerbated cortical porosity phenotype. Bone. January 2022;154:116228. |
1 |
0 |
| 2022 |
Swallow EA, Metzger CE, Newman CL, Chen NX, Moe SM, Allen MR. Cortical porosity development and progression is mitigated after etelcalcetide treatment in an animal model of chronic kidney disease. Bone. April 2022;157:116340. |
2 |
0 |
| 2022 |
Damrath JG, Metzger CE, Allen MR, Wallace JM. A novel murine model of combined insulin-dependent diabetes and chronic kidney disease has greater skeletal detriments than either disease individually. Bone. December 2022;165:116559. |
3 |
0 |
| 2023 |
Surowiec RK, Saldivar R, Rai RK, Metzger CE, Jacobson AM, Allen MR, Wallace JM. Ex vivo exposure to calcitonin or raloxifene improves mechanical properties of diseased bone through non-cell mediated mechanisms. Bone. August 2023;173:116805. |
1 |
0 |
| 2023 |
Newman CL, Surowiec RK, Swallow EA, Metzger CE, Kim J, Tomaschke AA, Chen NX, Allen MR, Wallace JM, Moe SM, Wu Y-C, Niziolek PJ. Assessing cortical bone porosity with MRI in an animal model of chronic kidney disease. Bone. August 2023;173:116808. |
0 |
0 |
| 2007 |
Allen MR, Burr DB. Mineralization, microdamage, and matrix: how bisphosphonates influence material properties of bone. BoneKEy Osteovision. February 2007;4(2):49-60. |
26 |
18 |
| 2008 |
Allen MR, Reinwald S, Burr DB. Alendronate reduces bone toughness of ribs without significantly increasing microdamage accumulation in dogs following 3 years of daily treatment. Calcif Tiss Int. May 2008;82(5):354-360. |
25 |
17 |
| 2020 |
Metzger CE, Swallow EA, Allen MR. Elevations in cortical porosity occur prior to significant rise in serum parathyroid hormone in young female mice with adenine-induced CKD. Calcif Tiss Int. April 2020;106(4):392-400. |
6 |
2 |
| 2008 |
Robling AG, Niziolek PJ, Baldridge LA, Condon KW, Allen MR, Alam I, Mantila SM, Gluhak-Heinrich J, Bellido TM, Harris SE, Turner CH. Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin. J Biol Chem. February 29, 2008;283(9):5866-5875. |
138 |
127 |
| 2007 |
Eswaran SK, Allen MR, Burr DB, Keaveny TM. A computational assessment of the independent contribution of changes in canine trabecular bone volume fraction and microarchitecture to increased bone strength with suppression of bone turnover. J Biomech. 2007;40(15):3424-3431. |
16 |
12 |
| 2008 |
Siegmund T, Allen MR, Burr DB. Failure of mineralized collagen fibrils: modeling the role of collagen cross-linking. J Biomech. 2008;41(7):1427-1435. |
31 |
27 |
| 2009 |
Eswaran SK, Bevill G, Nagarathnam P, Allen MR, Burr DB, Keaveny TM. Effects of suppression of bone turnover on cortical and trabecular load sharing in the canine vertebral body. J Biomech. March 11, 2009;42(4):517-523. |
2 |
2 |
| 2019 |
Hammond MA, Wallace JM, Allen MR, Siegmund T. Mechanics of linear microcracking in trabecular bone. J Biomech. January 23, 2019;83:34-42. |
12 |
12 |
| 2007 |
Allen MR, Burr DB. Three years of alendronate treatment results in similar levels of vertebral microdamage as after one year of treatment. J Bone Miner Res. November 2007;22(11):1759-1765. |
22 |
14 |
| 2020 |
Chen NX, Srinivasan S, O'Neill K, Nickolas TL, Wallace JM, Allen MR, Metzger CE, Creecy A, Avin KG, Moe SM. Effect of advanced glycation end‐products (AGE) lowering drug ALT‐711 on biochemical, vascular, and bone parameters in a rat model of CKD‐MBD. J Bone Miner Res. March 2020;35(3):608-617. |
4 |
4 |
| 2021 |
Noonan ML, Ni P, Agoro R, Sacks SA, Swallow EA, Wheeler JA, Clinkenbeard EL, Capitano ML, Prideaux M, Atkins GJ, Thompson WR, Allen MR, Broxmeyer HE, White KE. The HIF-PHI BAY 85-3934 (Molidustat) improves anemia and is associated with reduced levels of circulating FGF23 in a CKD mouse model. J Bone Miner Res. June 2021;36(6):1117-1130. |
0 |
0 |
| 2011 |
Pemmer B, Hofstaetter JG, Meirer F, Smolek S, Wobrauschek P, Simon R, Fuchs RK, Allen MR, Condon KW, Reinwald S, Phipps RJ, Burr DB, Paschalis EP, Klaushofer K, Streli C, Roschger P. Increased strontium uptake in trabecular bone of ovariectomized calcium-deficient rats treated with strontium ranelate or strontium chloride. J Synchrotron Radiat. November 2011;18(6):835-841. |
0 |
0 |
| 2008 |
Fuchs RK, Allen MR, Ruppel ME, Diab T, Phipps RJ, Miller LM, Burr DB. In situ examination of the time-course for secondary mineralization of Haversian bone using synchrotron Fourier transform infrared microspectroscopy. Matrix Biol. January 2008;27(1):34-41. |
21 |
19 |
| 2008 |
Allen MR, Gineyts E, Leeming DJ, Burr DB, Delmas PD. Bisphosphonates alter trabecular bone collagen cross-linking and isomerization in beagle dog vertebra. Osteoporos Int. March 2008;19(3):329-337. |
27 |
20 |
| 2009 |
Tang SY, Allen MR, Phipps R, Burr DB, Vashishth D. Changes in non-enzymatic glycation and its association with altered mechanical properties following 1-year treatment with risedronate or alendronate. Osteoporos Int. July 2009;20(6):887-894. |
56 |
33 |